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Abstract
Background: This paper discusses the establishment of a clinical trial of an Ebola vaccine candidate in Kambia
District, Northern Sierra Leone during the epidemic, and analyses the role of social science research in ensuring that
lessons from the socio-political context, the recent experience of the Ebola outbreak, and learning from previous
clinical trials were incorporated in the development of community engagement strategies. The paper aims to
provide a case study of an integrated social science and communications system in the start-up phase of the
clinical trial.
Methods: The paper is based on qualitative research methods including ethnographic observation, interviews with
trial participants and key stakeholder interviews.
Results: Through the case study of EBOVAC Salone, the paper suggests ways in which research can be used to
inform communication strategies before and during the setting up of the trial. It explores notions of power, fairness
and trust emerging from analysis of the Sierra Leonean context and through ethnographic research, to reflect on
three situations in which social scientists and community liaison officers worked together to ensure successful
community engagement. Firstly, a section on “power” considers the pitfalls of considering communities as
homogeneous and shows the importance of understanding intra-community power dynamics when engaging
communities. Secondly, a section on “fairness” shows how local understandings of what is fair can help inform the
design of volunteer recruitment strategies. Finally, a section on “trust” highlights how historically rooted rumours
can be effectively addressed through active dialogue rather than through an approach focused on correcting
misinformation.
Conclusion: The paper firstly emphasises the value of social science in the setting up of clinical trials, in terms of
providing an in depth understanding of context and social dynamics. Secondly, the paper suggests the importance
of a close collaboration between research and community engagement to effectively confront political and social
dynamics, especially in the context of an epidemic.
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Background
The Ebola epidemic in 2014 and 2015 in the West
African countries of Guinea, Liberia and Sierra Leone
was unprecedented in its size, over 28,000 people were
infected and around 11,000 died [1]. In Sierra Leone, as
of April 2016, 14,124 cases were registered, 3,956 of
whom died [2]. As the epidemic took hold in Sierra
Leone, Guinea and Liberia, reports were rife of instances
of community resistance to medical intervention, com-
munities’ mistrust and avoidance of healthcare centres,
and stigmatisation of health workers and survivors [3–6].
Wilkinson and Leach argue that such resistance and
mistrust must be understood through consideration of a
long history of structural violence [7]. First as a central
port in the Atlantic slave trade and then as a mining col-
ony for the British Empire, a substantial proportion of
Sierra Leone’s encounters with outsiders were primarily
extractive [8, 9]. The country’s postcolonial past was
similarly marred by years of oppressive and corrupt rule,
which deprived the majority of the population of access
to education, employment and basic healthcare services
[10, 11] This was followed by a brutal ten year civil war
(1991–2002), in which rebelling factions fought against
authorities as symbols of a “rotten system”, but in the
process all sides of the conflict systematically perpe-
trated violence against the civilian population [12–15].
Following the war and up until the Ebola epidemic
erupted in 2014, the country was undergoing a long and
difficult process of post-war reconstruction, during
which citizens, government and foreign partners were
attempting to build trustworthy governance structures at
national and local level [10, 16]. The continuing poverty
(Sierra Leone is ranked 181st in the Human Develop-
ment Index) and inequalities experienced by citizens and
this deep rooted historical legacy of distrust in govern-
ment and outside agencies can help explain challenges
faced by those attempting to contain the spread of the
Ebola virus [7].
The nature and rapidity of the spread of the disease
also made clear the importance of understanding the
socio-cultural dimensions of disease and the historical
context which shapes them [7]. The initial response to
the outbreak was undertaken by national government,
national and international non-governmental organisa-
tions (NGOs), followed by the global UN led responses.
Whilst prioritizing treatment centres, international orga-
nisations also focused their responses on surveillance,
case management, safe burials, contact-tracing and
community sensitization [17]. At first, interactions with
communities focused on “sensitisation”, emphasising
that local populations lacked knowledge on Ebola and
that “traditional practices” spread disease [18]. As
Chandler et al note, these strategies paid “little attention
to the historical, political, economic, and social contexts
in which they are delivered…[and] they reinforce
external perceptions that local beliefs and practices are
barriers to be overcome through persuasion or counter-
balanced with incentives” ([18], p.1275).
As the epidemic developed and lessons were learned,
examples emerged of changes in the engagement of local
populations, as some aspects of the response adapted to
deal more effectively with socio-cultural dimensions,
taking seriously the importance of understanding com-
munities’ needs and constraints and building trust. For
example, safe burials that prevented people from wash-
ing dead bodies were made more acceptable by seeking
the approval of local leaders, discussing the practices
with the family of the deceased, burying the body in the
presence of the community and including components
of burial rituals such as Muslim shrouds on coffins [19].
The Ebola response’s learning curve was thus character-
ized by a gradual move away from attempts to correct
misinformation towards the engagement of communi-
ties. In a recent analysis of the epidemic, Laverack and
Manoncourt found that in a context of fear, mistrust and
resistance, due to both the structural and political
context as well as experiences of poor quality health
care, utilising bottom up approaches to communication,
which included a respect for local knowledge, was more
effective [17]. As anthropologists working in these
contexts have argued throughout the epidemic, rather
than viewing customs and culture as barriers of re-
sistance, it is more useful to consider how culture
can adapt, something that, as Richards et al suggest,
ought to be done in continuous consultation with
local communities [20]. Reflecting on the West Afri-
can Ebola epidemic, Abramowitz et al highlight how
“under conditions of extreme stress, culture can be
flexible and supple in response to extreme circum-
stances and the arrival of new information (such as
public health messages), and make allowances in
extraordinary conditions” ([21], p.4). The Ebola epi-
demic, in other words, rendered evident the benefits
of engaging deeply with affected countries’ social, cul-
tural and political context in order to understand
communities’ response to the disease and to work
with them to find ways to deal with crises.
The speed with which the epidemic grew and its
extent demanded not only a rapid and coordinated re-
sponse from international agencies and local authorities,
but also called for the fast-tracked development of
vaccines and other potential preventative and treatment
technologies. This required the establishment of prophy-
lactic vaccine trials in an epidemic context, which
presents particular challenges for both the communities
and the trialists. The setting up of such trials requires
learning lessons from the historical and political context
and from the experiences of the response to the
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outbreak, as described above, especially in terms of
rooting communication strategies on deep understand-
ing of socio-cultural contexts as adaptable and dynamic
and on effective and active engagement of community
members. In addition, the setting up of trials can benefit
from learning from anthropological research on clinical
trials related to other stigmatised diseases in resource
poor contexts.
There is a growing body of work that is exploring
complex political economy and social justice questions
that emerge in communities where clinical trials are tak-
ing place [22–24]. These address broader ethical ques-
tions beyond the focus on informed consent. Molyneux
and Geissler, for example, argue that this often does not
take into account broader issues of inequities in wealth,
health status and health care resources between the re-
searchers and the researched ([24]; see also [22, 23, 25]).
Dugas and Graham similarly suggest that standardised
consent processes may be inadequate in contexts where
translation is required, where socio-economic inequal-
ities are stark and where collective consent may be im-
portant alongside individual consent [26]. Beyond these
issues, there has been a growing body of research on the
local effects of medical research on participants and
their communities [24, 27–29]. Such research has re-
vealed the salience of social relations developed between
researchers and participants as well as the prevalence of
rumours and concerns [28–36]. This body of research
provides a foundation for developing strategies for
engaging local populations and participants in a
meaningful way grounded in the specificities of ethics
and social relations in resource-poor contexts.
Given the nature of the Ebola epidemic, and the spe-
cific fears and concerns that the disease invokes, as well
as the political history of Sierra Leone, the setting up of
a vaccine trial during the Ebola epidemic required
having an in-depth understanding of the epidemic and
its effects as well as building trust within communities.
With the prospect of such new encounters with
biomedicine for people in communities with very little
(and often no) experience of medical research, there is
also an urgent need to determine what rumours,
concerns, fears or mistrust emerge from dialogues with
community members and individuals involved in vaccine
trials and the ways in which such actors can be engaged
in addressing these and building trust.
This paper discusses the role of social science
(anthropology) and community liaison in supporting the
establishment of the EBOVAC-Salone prophylactic Ebola
vaccine trial in Kambia District, Northern Sierra Leone,
during July to August 2015, towards the end of the Ebola
epidemic. Through an exploration of notions of power,
fairness and trust emerging from analysis of the Sierra
Leonean context and through ethnographic research, the
paper discusses three situations in which the EBOVAC-
Salone social science and community liaison teams
worked together to ensure effective communication, to
develop appropriate recruitment strategies and to
address rumours about the trial.
The EBOVAC-Salone trial
In December 2014, the Innovative Medicines Initiative
(IMI) awarded funding from the Ebola + programme to a
consortia of research institutions to support the develop-
ment, manufacturing and deployment of a prime-boost
prophylactic Ebola vaccine regimen, in partnership with
private industry [37]. A portion of the IMI2 funding
awarded to the EBOVAC1 consortium is being used to
implement the EBOVAC-Salone study in Sierra Leone.
In addition to EBOVAC-Salone, IMI2 has also funded
the related EBODAC (Ebola Vaccine Deployment,
Acceptance and Compliance) consortium whose object-
ive is to conduct community engagement and communi-
cation to support the prime-boost Ebola vaccine trials
and roll-out of vaccines, if proven effective.
The EBOVAC-Salone study aims to assess the safety
and immunogenicity of the Ad26.ZEBOV/MVA-BN-Filo
prime-boost regimen in a population affected by Ebola.
The study is being carried out in Kambia District in
Northern Sierra Leone. Stage 1, an open label, safety and
immunogenicity study of the prime boost vaccine in 43
healthy adults aged 18 years or older has completed the
vaccination phase. The first participants to volunteer for
the study were screened for eligibility on 20 September
2015 and vaccination began on 8 October 2015. In stage
2, a randomised, controlled, safety and immunogenicity
study, 688 individuals will be screened and will be
randomised to the prime boost vaccine or a control
vaccine.1 Adults, adolescents and children aged one year
or older will be included in this trial. Plans for additional
stages are being finalized in consultation with the Sierra
Leonean authorities and international health agencies.
EBOVAC-Salone is coordinated by the London School
of Hygiene &Tropical Medicine (LSHTM) working in
partnership with Sierra Leone’s Ministry of Health and
Sanitation and the College of Medicine and Allied
Health Sciences. The EBOVAC-Salone study is one of
several vaccine trials set up in West Africa during and in
the immediate aftermath of the epidemic [38, 39].
Methods: the community liaison and social
science system
Engagement with the community in Kambia in the
run-up to stage 1 of the EBOVAC-Salone study was con-
ducted by a community liaison team and a social science
team. The two teams were recruited locally.
The community liaison team, comprising nine locally-
recruited staff, supervised by two LSHTM staff members,
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was responsible for implementing EBOVAC-Salone’s
community engagement strategy. The team was comple-
mented by an external communications manager who
monitors rumours and concerns about the trial beyond
the Kambia District and also provides information about
the trial at national and international levels.
EBOVAC Salone was the first vaccine trial of any kind
to have taken place in the study area, and the country as
a whole has had limited experience of medical research.
The community liaison team members thus received
background training on clinical trials, with a particular
emphasis on the difference between communication to
support clinical trials and communication and social
mobilisation for routine or proven interventions. The
community engagement strategy for Stage 1 involved
engaging with all levels of the community – from elected
and traditional leaders to individual households -
through a variety of channels. These included undertak-
ing one-to-one engagement with key stakeholders,
holding public meetings in partnership with influential
civil society leaders, organising community meetings
supported by local and traditional leaders, conducting
house-to-house sensitisation visits, and hosting radio
chat shows and phone-ins on local radio within Kambia
District.
A Participant Advisory Group (PAG) was also set up,
serving as a means through which study participants
were encouraged to openly discuss their experiences of
participating in the EBOVAC-Salone study with each
other. The purpose of the latter group was to address
concerns, share views, expose perceived barriers to en-
rolment and to share information where necessary. This
group is entirely participant-led and at the first meeting
the participants elected a Chairman and representative
committee. For Stage 1, trial participants were invited to
join the group by field workers who visited their homes
in the initial seven days following vaccination. The
frequency, structure and agendas of these meetings were
decided by the group members themselves. The PAG is
continuing to support stage 2, where 99 participants
have enrolled to date.
The social science team was made up of four locally
recruited research assistants, a data analyst and a
transcriber, led by an LSHTM social scientist based in
Kambia. The team was responsible for conducting
anthropological research to examine community and
participant perceptions and experiences of the EBOVAC
Salone vaccine study, including any rumours and con-
cerns around the trial and the vaccine. In addition, the
team explored the socio-cultural context and percep-
tions of illness and disease in the community where
Stage 1 was taking place. The methods used for this
research were: ethnographic observation, focus group
discussions, in depth interviews, and exit interviews with
participants as they completed their visit to the vaccin-
ation clinic. Ethical approval for this study was granted
by the ethics committees of LSHTM and Sierra Leone.
Ethnographic observations were carried out in key
areas in Kambia and trial clinics to explore community
dynamics; social interactions around the clinic; commu-
nity narratives about EVD and the clinical trials; and to
trace any ongoing rumours and concerns emerging at
community level. Focus group discussions were carried
out with both community members and with trial partic-
ipants to discuss perceptions and experiences of the trial.
In depth interviews were carried out with 6 Stage 1
Participants and 16 Stage 2 participants, interviewed
after prime and boost vaccination, and with approxi-
mately 20 key stakeholders in Kambia. At the time of
writing the Stage 2 research was ongoing. The data for
Stage 1 was analysed through thematic and framework
analysis. Framework analysis was used to answer the
specific research objectives. A coding tree was developed
according to the key research questions. Interview
transcripts were coded according to this coding tree.
Thematic analysis was used to develop emerging themes
not identified by the research objectives.
The insights for this paper are based primarily on the
ethnographic research carried out in Kambia in the three
months preceding the opening of the trial. As the epi-
demic continued to ravage the country, and as Kambians
lived under military curfew and constant news of Ebola
cases, the trial team was renovating clinics, building
laboratories and holding high-level conversations with
key stakeholders. During the preparation phase for Stage
1, ethnographic encounters in local markets, attaya2
bases, poyo3 bars, shops and okada4 parking grounds
enabled the research team to develop a rich and
complex picture of Kambia’s community dynamics, the
everyday struggles and concerns of its inhabitants during
the outbreak, their beliefs and fears about medical
intervention and their views on the study that was about
to open in their town.
Results: communications and social science
in action
During the preparation phase, the social science and
community liaison teams developed a feedback system
to inform rapidly research-driven communication strat-
egies. Weekly meetings had three main purposes. Firstly,
the social science team provided feedback on commu-
nity engagement plans based on their research on the
socio-cultural context, local community dynamics and
perceptions of the vaccine trial. Secondly, the meetings
brought up any issues encountered by the trial team or
the community liaison staff that required further
research by the social science team, such as the design
of the recruitment strategies outlined below. Thirdly, the
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social science team reported on any rumours or con-
cerns identified in the community. These rumours and
concerns were communicated to the community liaison
team anonymously in order not to breach confidentiality
and to maintain the independence of the social science
research. Following feedback, the community liaison
staff brainstormed strategies to respond to concerns or
rumours. Such strategies depended on the specific issue
raised, but usually involved considering different and
creative avenues for discussion with the community on
the issue, reviewing messaging to actively engage with
the issue at hand, and determining who the best person
in the team was to respond and through which channel.
When an urgent or potentially harmful rumour had been
identified, this was reported immediately to the trial
manager in Kambia and to the principal investigators.
This section of the paper discusses three examples of
challenges faced by the trial team during the set-up
phase of the study. These case studies reflect how
lessons gained from knowledge of the country’s context,
the experiences of the Ebola response and knowledge
gained during previous trials helped inform the commu-
nity engagement strategies and responses to issues as
they came up. The examples are arranged through three
key themes: power, fairness and trust. Each case study
begins with a reflection on the context facing the trial
team, then offers insights from the ethnographic
research and finally considers the implications for
community engagement strategies. These case studies
elucidate the importance of research-driven mobilisation
strategies, as well as the inevitable limitations on trialists’
ability to engage with all aspects of complex community
dynamics.
Power
The notion of “community” can often hide its heteroge-
neous nature and constant, underlying negotiations and
contestations of power. The commonly used notion of
‘community’ used for example in public health cam-
paigns and mobilization strategies can in fact hide com-
plexities engendered by struggles over status, authority
and economic resources. Questioning whose voice is
heard, and the ways in which community ‘leadership’ is
contested and in many ways produced by external inter-
ventions are at the heart of an understanding of commu-
nities as heterogeneous in and in flux. In Sierra Leone,
Mariane Ferme has identified an accepted division be-
tween public and secret spheres, that is, a widely shared
assumption that politics happens in different places,
some public and some secret, and that covert strategies
play a fundamental role in the working of politics [40].
This means that political intentions are permanently am-
biguous, something that Ferme sees as “one of the defin-
ing features of postcolonial subjectivity in Sierra Leone”
([40], p.161). In what she defines as the “dialogics of
publicity and secrecy”, overt acts of obedience are often
paralleled by covert defiance. This first case study shows
how these complicated, contextual and often hidden
configurations of power and struggles over economic
resources can impact on a vaccine trial’s mobilization
strategy.
The challenges posed by community power dynamics
became clear from the start of the engagement process.
Community engagement for the EBOVAC Salone study
began two months before the start of the trial with a
series of community meetings, often chaired by various
local authorities. The meetings were attended by the
community liaison team, who presented information
about the trial and who were ready to answer questions
from the audience, and by the social science team,
whose role was to observe, take notes and provide sup-
port if required. The meetings brought together groups
of people identified as “key stakeholders”, as representa-
tives of various important societal groups, such as area
chiefs, market traders, teachers and civil society activists.
At the meetings, stakeholders were provided with
information about the trial and were given time to ask
questions, raise concerns and offer suggestions.
A few days after one of the community meetings about
the EBOVAC Salone Trial, the social science team was
approached during daily ethnographic observations by a
small group of ‘stakeholders’ who had attended one of
the meetings. In exchange for the promise of absolute
confidentiality, they asked that their concerns be heard.
They reported that, while they had been asked in the
EBOVAC Salone public meetings to discuss the vaccine
trial with their communities and constituencies through
smaller local meetings they felt unable to do so. They
asked to meet at a separate time to explain their
concerns. The next day the team met the group at one
of their homes, and they began telling their story. They
recounted how they felt that their position as respected
leaders in their community had been undermined and
that, as a consequence, their ability to mobilise their
communities to participate in the trial was curtailed.
They attributed the erosion of their power to the
‘selfishness’ of those they identified as ‘big’ leaders in
Kambia, whom they blamed for failing to share the
financial resources coming into the district. They voiced
an assumption that powerful leaders must have ‘eaten’
significant amounts of Ebola funds before it could reach
their communities.5 Emphasising the correlation be-
tween financial power and ability to command respect in
their communities, these ‘small’ leaders argued that due
to their economic struggles, they found themselves
having to resort to borrowing money from their
community members, which diminished their ability to
command respect.
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Regardless of the veracity or legitimacy of these
allegations, these assumptions about the role of powerful
authorities were widely reported during ethnographic
research and they created significant amounts of discon-
tent and quiet mistrust in authority figures in Kambia,
as evidenced by the ‘small leaders’ private confessions.
Despite dancing and clapping at public meetings, these
‘small’ leaders argued that they were unable and unwill-
ing to act as spokespeople for local matters such as the
vaccine trial, because they felt that their communities no
longer respected them.
Although it was unclear whether this was in fact the
reason for their decision to refrain from supporting the
vaccine trial through the organisation of area meetings,
the community leaders utilised these conversations to
voice their dissatisfaction with the present structure of
authority. Their arguments point to the importance of
taking into account what are essential, but often hidden
and unspoken, contestations of power within communi-
ties. The “dialogics between publicity and secrecy” exem-
plified by the reluctance to hold public meetings despite
their public assertions of support, offers a salient ex-
ample of the broader importance of taking into account
the heterogeneity of community. Whilst community en-
gagement meetings appeared to be received positively in
Kambia, such manifest support could not be assumed to
translate into community-wide acceptance. Insights such
as those from the “small” leaders reveal that established
power structures are not indisputably representative, nor
are appointed leaders necessarily trusted by all sections
of the population. Internal struggles over status and eco-
nomic resources, as well as mistrust and disputes over
rightful loci of authority must be taken into account.
This cognizance of the contested nature of power
undoubtedly creates its own challenges. Undoubtedly,
having key and recognised stakeholders at the EBOVAC
Salone community meetings was extremely valuable and
its significance for a large number of Kambians cannot
be underestimated. However, recognising that power is
not always straightforward and that communities are
fragmented is an important foundation for building
more nuanced, sensitive and genuine engagement.
Ethnographic observation’s illustration of the deep-
rooted contestations of power put forward by the “small”
leaders and the political economy underpinning them,
cannot be directly addressed by a community engage-
ment team in a clinical trial. However, the social science
and community liaison teams’ ability to identify such
dynamics made it possible to initiate internal discussions
about how to reconcile the importance of involving
established authorities while diversifying engagement
strategies to reach different sections of the community.
This meant for example holding targeted sensitisation
sessions in areas such as markets and popular meeting
places, and holding radio talk shows in addition to key
community leader-led meetings.
Fairness
Notions of fairness are inevitably shaped by local under-
standings of morality, historical legacies and individual
experiences [41]. In Sierra Leone, conversations around
fairness often revolve around the widespread assumption
that access to resources relies on having a strong
sababu, that is, a connection with people in positions of
power. Lacking a sababu is frequently cited as a key
reason why large numbers of Sierra Leoneans live in
poverty, with limited access to jobs and basic healthcare
[42]. Strong critiques of “connectocracy”, furthermore,
are paralleled by assumptions that nepotism is the only
way to access resources. Beliefs about fairness were also
central to the unfolding of the ten year civil war, for ex-
ample as discontent surrounding chiefly abuse of powers
in terms of forced community labour demanded of young
men, featured prominently in combatants’ accounts of
their motivations for joining rebelling forces [43].
In clinical research the notion of fairness emerges at
several stages of the research, from concerns about equal
treatment of control and treatment groups, to issues of
compensation and the addressing of potential medical
complications. In the initial stages of trial design, which
this paper focuses on, engaging with local ideas of fair-
ness was an especially important in trialists’ discussions
surrounding the design of a volunteer recruitment
strategy. The senior investigators and trial team expected
the issue of participant recruitment in EBOVAC Salone
to be challenging, especially in an epidemic context, in a
country with little experience of clinical trials. Conse-
quently, the design of a recruitment strategy was
discussed at length, combining senior trialists’ expertise
of vaccine trials in other contexts with conversations
with local staff and anthropological insights. As Ezekiel
et al. have pointed out: fair selection of the study popu-
lation is a key benchmark of ethical clinical research in
developing countries [44]. As such, the trial team had to
consider not only their own understandings of what
would be an effective trial design that would ensure that
the results it provided would be scientifically valid and
representative of the community as a whole, but also
how the Kambia community would perceive the
selection of volunteers.
Initial discussions centred on a number of design op-
tions, including individuals coming directly to the clinic
to volunteer or having a key authority figure canvass for
volunteers. Given the context discussed above, these
options raised concerns that the trial would be liable to
complaints of unfairness, as well as the fact that the en-
rolled participants would be likely to be unrepresentative
of the population as a whole. Firstly, given assumptions
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that access to resources is assumed to be based on
“connectocracy”, there was the potential that, given the
limited number of participants required, people could
have assumed that the “big ones” were picking them-
selves and those they knew. On the other hand, using
key authority figures to compile a list of volunteers, or
asking key stakeholders to be the first volunteers could
have led to accusations of forced participation. Given
Sierra Leone’s history of conflict, the potential for
participant recruitment to be likened to forced
conscription also added sensitivities for the trial
recruitment process.
In consideration of these concerns, and after extensive
consultation with the principal investigators, trial
sponsor and the trial manager, the community liaison
team opted for a public lottery of household numbers
followed by individual visits through which people would
be offered the opportunity to volunteer in the vaccine
trial. This involved inviting community members to ob-
serve and take part in the selection of 100 households
(to begin with) from a bag containing all household
numbers in Kambia town.6 These households were then
visited individually by community liaison officers who
explained in detail the purpose and procedures of the
trial and voluntary nature of the process and provided
these randomly selected households with the opportun-
ity to volunteer.
Notions of fairness, like power, are contested and there
are limitations in the extent to which any design can
avoid criticism. For example, as initial fears surrounding
the new vaccine trial subsided, some community mem-
bers expressed worries that the lottery system would not
be able to taking into account those who were eager to
take the vaccine.7 However, as one civil society activist
noted, using a lottery system meant that “bad name
done komot dae” (the trial has avoided a bad reputa-
tion).8 Had it not been done through a public lottery,
she argued, allegations of unfairness would have been
widespread.9
Trust
A major challenge in preparing for this vaccine trial in
Sierra Leone during the Ebola epidemic was the high
levels of fear and mistrust which, as discussed, had
develop through a history of oppressive rule and conflict.
The epidemic was accompanied by a plethora of stories
and rumours that starkly exposed the lack of confidence
in government authorities, medical practitioners, and
external agencies [6, 45, 46]. This was made clear by the
widespread belief that Ebola was a man-made, popula-
tion control strategy in view of the next Presidential
elections; that people were killed inside ambulances by
being asphyxiated by chlorine; or that new cases were
fabricated in order for Ebola response workers to profit
from the protracted crisis [6, 47] These rumours have
too often been treated as a sign that populations are
“misinformed” at best, “ignorant” at worst, and are thus
simply in need of better information in order to change
their behaviour [18]. However, these rumours reflect
broader anxieties rooted in a much deeper socio-
political context, and explain resistance to the Ebola
response at the height of the epidemic. Anxieties sur-
rounding the government’s and international partners’
plans reveal fractures in citizens’ trust in the healthcare
sector, which is seen as corrupt and inefficient, and
reflects the fragility of the social contract rebuilt in the
aftermath of Sierra Leone’s civil war. Understanding
public perceptions, rumours and concerns in this fragile
context and creating multiple forums for dialogue and
trust-building, were an essential foundation for more
trial-specific community engagement.
As communities learned about the planned vaccine
trial in Kambia, the ethnography revealed that concerns
surrounding the Ebola outbreak and the response to it
were initially transposed to ideas about what the trial
would involve. One evening, when the social science
team discussed perceptions of the vaccine trial with a
group of young men, one of them said he had a concern
he had previously been ashamed to share. He said that
he had heard that there was a “world blood bank” that
was lacking type O blood. He argued that survival at the
Ebola treatment centres had been determined by one’s
blood type, as those with type O blood were killed for
their blood. Survivors were those whose blood type was
not needed by the world blood bank and who were thus
allowed to return to their communities alive. He
reported that he had been afraid during the Ebola
outbreak because he knew his blood type was O. Having
heard in several community meetings that blood would
be taken during the process of the vaccine trial, he asked
whether this was actually a continuation of the blood
stealing that he believed had been going on since the
outbreak of Ebola.
In other ethnographic encounters in Kambia’s key
congregation areas, the social science team frequently
recorded links being drawn between the epidemic and
the vaccine study by referring to the impending trial as
“Ebola Phase Two”. As with the young man’s concern
about blood stealing, this title referred to the concern
that the trial might be a plan to “finish off” those who
had managed to escape death during the outbreak. As
one trial participant put it when discussing the rumours
he had heard that “[the vaccine] is a slow poison the
white man has made to kill us”.10
While maintaining a commitment to the confidential
nature of research conversations, the social science team
alerted the community liaison team when these fears
and articulations of mistrust emerged. The community
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liaison team responded by visiting areas such as the
town’s market where the idea of the vaccine being “Ebola
Phase Two” had taken root. Being aware of the particu-
lar nature of anxieties surrounding blood-donation in
the context of the Ebola outbreak meant that the
community liaison team encouraged debates and conver-
sations through community meetings, one-on-one con-
versations and radio shows to discuss the role of blood
taking in the vaccine trial. They provided explicit infor-
mation about the destination and use of blood samples
and the fact that samples could be destroyed if the
participant so wished once the study was over. They also
invited questions, challenges and suggestions. Represen-
tatives of different societal groups who had previously
attended community engagement events hosted their
own meetings, which the community liaison team
attended as guests, encouraged open and often heated
debates, and also enabled the creation of spaces for
expressing and confronting anxieties rather than simply
rejecting them as misinformation.
In another example, community meetings and ethno-
graphic encounters brought up the issue of the insur-
ance that would be provided for participants in case of
any long-term side-effects from the vaccine. This had
sparked worried conversations about the likelihood that
if the trial provided insurance it meant the trialists ex-
pected people to die in the process. Concerns identified
by the social science team were fed back to the commu-
nity liaison team. The team developed a strategy to help
allay fears around this rumour, including a new message
about the provision of insurance that also emphasised
the safety of the vaccine. An influential individual in that
particular community, who had worked with the
community liaison team, volunteered to assist with
disseminating the message and dispelling the rumour
through discussions in the area where the rumour had
emerged.
Such rumours represent more generalised concerns
about medical interventions; they are not simple
misunderstandings but are rather rooted in histories of
exploitation and mistrust. Therefore, whilst immediate
messaging was seen to be important, the main role of
the teams was to develop communication to understand
community concerns, and the drivers behind these
concerns, and to work to build trust through ongoing
active and inclusive dialogue.
Discussion
Carrying out vaccine trials in the context of an infectious
disease epidemic with high mortality in a developing
county recovering from years of internal conflict brings
significant challenges. The EBOVAC Salone trial was set
up during the Ebola outbreak as affected populations
were trying to make sense of the disease and its
devastating impact on families and communities. In
addition, the epidemic has laid bare, and sometimes
exacerbated, mistrust in the healthcare system, elected
officials and external health interventions. In order to
understand some of the concerns surrounding the trial,
it was crucial that the teams took into account how the
Ebola epidemic has affected social relations and power
as well as local ideas about the Ebola response, including
interactions with Western medicine and experiences of
community engagement. Even more broadly, it was
important for the two teams to work together to engage
effectively with the community dynamics and power
constellations highlighted by anthropological research.
Such understandings of the community in which the
trial was being set up have helped the teams to ensure
that communities and participants are given an
opportunity to voice concerns and to work with them to
address mistrust. Knowledge of contested power, for
example, allowed the team to listen to the voice of
“small leaders” and to take into account their potential
to disengage from the trial.
This paper has offered illustrations of how social sci-
ence and community liaison team worked in concert to
shape engagement strategies and volunteer recruitment
mechanisms. The examples discussed here show the
value of research-driven communications and offer im-
portant lessons for future trials. Firstly, they demonstrate
the importance of real-time social science research in
the setting up of a vaccine trial. Social science
researchers can act as independent “eyes and ears of the
trial”, listening to fears, concerns and suggestions. Sec-
ondly, an in depth understanding of community power
dynamics highlights the importance of diversifying
communication methods and avenues for engagement.
As shown by the concerns of the “small” community
leaders, contestations of power can be muted and hidden
but can nonetheless affect the relationship between the
vaccine trial and the community. As such, using a var-
iety of communication channels, rather than relying
solely on established leadership, can ensure messages
reach different sectors of the community. Thirdly, an
understanding of community dynamics and local social
norms through ongoing dialogue can help inform the
set-up of a trial from the start as evidenced by the estab-
lishment of a public lottery for volunteer recruitment.
Finally, a focus on listening to and understanding
rumours revealed deeper concerns about health inter-
ventions stemming from histories of mistrust, rather
than simply being “misunderstandings”.
Conclusion
This paper reveals that lessons learned from ethnograph-
ies of other trials about political and social inequities,
social relations and rumours and concerns have been
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heeded. However, they also highlight very specific and
local concerns in the context of the Ebola epidemic,
which can only be revealed by on-going and “close to
the ground” social science research and effective and
dynamic community engagement.
Notes
More information on the EBOVAC Trial can be found
at: http://www.ebovac.org and https://clinicaltrials.gov/
ct2/show/NCT02509494?term=EBOVAC&rank=1.
Endnotes
1The vaccine being used as the active control is the
WHO-prequalified Meningitis ACWY vaccine. This is
given as a prime dose at Day 1 and a placebo as the
boost dose, except in children under the age of 2 years
who are given 2 doses of the active control vaccine.
2Chinese gunpowder tea
3Palm wine
4Commercial motorbikes
5These interpretations, and the expectations that they
raised, must also be understood in the context of the
traditional practice of paying ‘kola’, a ‘greeting gift’, to
authorities and gatekeepers, such as chiefs in order to
begin community consultations, as well as the
widespread payment of traditional authorities and land
custodians in order to facilitate business, such as in the
mining industry [48, 49].
6Before carrying out a lottery, the social science team
mapped Kambia Town using Global Positioning System
(GPS) technology and produced a list of all households
in the town, as this was not available at the time.
7Community Focus Group Discussion, Kambia, 23
November 2015
8Key Informant Interview, Kambia, 19 October 2015
9The fact that there may have been accusations of
unfairness seems to suggest a particular eagerness (or
the expectation of eagerness) to participate amongst
Kambia residents in the initial stages, and during the
epidemic. This begs the question of what people’s motiv-
ation for joining may have been, what perceived incen-
tives may play a role and whether certain selection
biases may have been at play. Determining what factors
influence participants’ decisions to enroll in the EBO-
VAC trial is a key component of the social science re-
search taking place throughout the running of the trial.
This reflects the contribution that qualitative research
can make by highlighting potential ethical issues as they
arise during a clinical research project.
10Exit Interview, Kambia, 20.10.2015
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